January

January 18, 2015

MiRNA-based molecular therapy for T2DM: MiRNA-150 promotes insulin secretion and inhibits glucose intolerance via down regulation of FFA2, 18/November/2014, 17.55

A recent study from the Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany shows that “Loss of FFA2 and FFA3 increases insulin secretion and improves […]
January 18, 2015

MiRNA-based therapy for Pulmonary Hypertension: MiRNA-105 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, 17.48

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Pulmonary Hypertension: MiRNA-105 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, […]
January 18, 2015

Natural product-based therapy for Cancer: Berberine increases the expression of FBXO11 via down regulation of its target gene, 18/January/2015, 17.43

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Natural product-based therapy for Cancer: Berberine increases the expression of FBXO11 via down regulation of its target […]
January 18, 2015

Molecular therapy for Pulmonary Hypertension: E2F3 inhibits pulmonary hypertension via down regulation of its target gene, 18/January/2015, 17.33

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Molecular therapy for Pulmonary Hypertension: E2F3 inhibits pulmonary hypertension via down regulation of its target gene, 18/January/2015, […]